These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Investigation of a potential scintigraphic tracer for imaging apoptosis: radioiodinated annexin V-Kunitz protease inhibitor fusion protein. Liao MH; Jan TR; Chiang CC; Yen KC; Liao TZ; Chen MW; Chi CW; Wun TC; Yen TC; Wey SP J Biomed Biotechnol; 2011; 2011():675701. PubMed ID: 21584284 [TBL] [Abstract][Full Text] [Related]
8. Selective inhibition of factor Xa is more efficient than factor VIIa-tissue factor complex blockade at facilitating coronary thrombolysis in the canine model. Lefkovits J; Malycky JL; Rao JS; Hart CE; Plow EF; Topol EJ; Nicolini FA J Am Coll Cardiol; 1996 Dec; 28(7):1858-65. PubMed ID: 8962577 [TBL] [Abstract][Full Text] [Related]
9. Preparation of Peptide and Recombinant Tissue Plasminogen Activator Conjugated Poly(Lactic-Co-Glycolic Acid) (PLGA) Magnetic Nanoparticles for Dual Targeted Thrombolytic Therapy. Chen HA; Ma YH; Hsu TY; Chen JP Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32294917 [TBL] [Abstract][Full Text] [Related]
10. Thrombolysis induced by intravenous administration of plasminogen activator in magnetoliposomes: dual targeting by magnetic and thermal manipulation. Liu CH; Hsu HL; Chen JP; Wu T; Ma YH Nanomedicine; 2019 Aug; 20():101992. PubMed ID: 30981818 [TBL] [Abstract][Full Text] [Related]
11. Fibrin-targeted direct factor Xa inhibition: construction and characterization of a recombinant factor Xa inhibitor composed of an anti-fibrin single-chain antibody and tick anticoagulant peptide. Hagemeyer CE; Tomic I; Jaminet P; Weirich U; Bassler N; Schwarz M; Runge MS; Bode C; Peter K Thromb Haemost; 2004 Jul; 92(1):47-53. PubMed ID: 15213844 [TBL] [Abstract][Full Text] [Related]
12. Comparison of enoxaparin, hirulog, and heparin as adjunctive antithrombotic therapy during thrombolysis with rtPA in the stenosed canine coronary artery. Leadley RJ; Kasiewski CJ; Bostwick JS; Bentley R; McVey MJ; White FJ; Perrone MH; Dunwiddie CT Thromb Haemost; 1997 Oct; 78(4):1278-85. PubMed ID: 9364998 [TBL] [Abstract][Full Text] [Related]
13. Conjunctive enhancement of enzymatic thrombolysis and prevention of thrombotic reocclusion with the selective factor Xa inhibitor, tick anticoagulant peptide. Comparison to hirudin and heparin in a canine model of acute coronary artery thrombosis. Sitko GR; Ramjit DR; Stabilito II; Lehman D; Lynch JJ; Vlasuk GP Circulation; 1992 Feb; 85(2):805-15. PubMed ID: 1735171 [TBL] [Abstract][Full Text] [Related]
14. Characterisation of a novel series of aprotinin-derived anticoagulants. I. In vitro and pharmacological properties. Stassen JM; Lambeir AM; Matthyssens G; Ripka WC; Nyström A; Sixma JJ; Vermylen J Thromb Haemost; 1995 Aug; 74(2):646-54. PubMed ID: 8585001 [TBL] [Abstract][Full Text] [Related]
15. Combination of platelet fibrinogen receptor antagonist and direct thrombin inhibitor at low doses markedly improves thrombolysis. Nicolini FA; Lee P; Rios G; Kottke-Marchant K; Topol EJ Circulation; 1994 Apr; 89(4):1802-9. PubMed ID: 8149546 [TBL] [Abstract][Full Text] [Related]
17. Thrombolysis and reocclusion in experimental jugular vein and coronary artery thrombosis. Effects of a plasminogen activator inhibitor type 1-neutralizing monoclonal antibody. Biemond BJ; Levi M; Coronel R; Janse MJ; ten Cate JW; Pannekoek H Circulation; 1995 Feb; 91(4):1175-81. PubMed ID: 7850956 [TBL] [Abstract][Full Text] [Related]
18. Procoagulant activity on injured arteries and associated thrombi is mediated primarily by the complex of tissue factor and factor VIIa. Speidel CM; Thornton JD; Meng YY; Eisenberg PR; Edgington TS; Abendschein DR Coron Artery Dis; 1996 Jan; 7(1):57-62. PubMed ID: 8773434 [TBL] [Abstract][Full Text] [Related]
19. Bioconjugation of recombinant tissue plasminogen activator to magnetic nanocarriers for targeted thrombolysis. Yang HW; Hua MY; Lin KJ; Wey SP; Tsai RY; Wu SY; Lu YC; Liu HL; Wu T; Ma YH Int J Nanomedicine; 2012; 7():5159-73. PubMed ID: 23055728 [TBL] [Abstract][Full Text] [Related]
20. Recombinant Tissue Plasminogen Activator-conjugated Nanoparticles Effectively Targets Thrombolysis in a Rat Model of Middle Cerebral Artery Occlusion. Deng J; Mei H; Shi W; Pang ZQ; Zhang B; Guo T; Wang HF; Jiang XG; Hu Y Curr Med Sci; 2018 Jun; 38(3):427-435. PubMed ID: 30074208 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]